November 6, 2015 — An expert panel to the FDA has voted that fluoroquinolone antibiotics like Levaquin and Avelox need stronger warnings about serious side effects, according to The Wall Street Journal.
The panel nearly-unanimously voted that current labels do not adequately warn about the risks of prescribing a fluoroquinolone for some of the most common sinus, lung, and urinary tract infections.
Investigators reviewed the FDA database of adverse events and published a report (PDF) ahead of the meeting. Fluoroquinolone antibiotics were linked to 178 cases of Fluoroquinolone-Associated Disability (FQAD), a “constellation of symptoms” that typically involved long-term pain, musculoskeletal events (tendon, joint, and/or muscle problems).
More than 30 individuals spoke at an open public hearing about their experiences with these side effects. Many described severe disability and decreased quality of life, according to MedScape Medical News.
According to the panel, fluoroquinolone antibiotics are associated with FQAD and the label should be revised:
“While the individual components are included in fluoroquinolone labels, a description of the constellation of disabling adverse events is not currently described in the fluoroquinolone labels.”
The FDA does not have to follow the panel’s recommendations, but it often does. In recent years, labels have been updated to include side effects like peripheral neuropathy (nerve damage), tendon injuries, cognitive problems, and more.
Do I have a Levaquin Lawsuit?
The Schmidt Firm, PLLC is currently accepting Levaquin induced injury cases in all 50 states. If you or somebody you know has been injured, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.